Stem Cell Therapy for Diabetes and Organ Diseases

At a Glance

  • Surgery duration: 1 to 3 hours (outpatient)
  • Anesthesia: Exclusively local anesthesia (tumescent anesthesia)
  • Preliminary examinations: Blood test, further examinations depending on the patient’s state of health
  • Check-ups: To be arranged on an individual basis

Request more information now

The number of diabetes cases being diagnosed is on the increase. In the case of type 1 diabetes, this is the beginning of a lifelong insulin therapy in order to replace the autologous hormone, which is essential to regulate blood sugar concentration. This therapy is frequently very unpleasant for the patient, as the hormone has to be injected under the skin several times a day.

At present, the treatment of diabetes with autologous stem cells from fat cannot generally be recommended, as there is not enough data available. There is, however, evidence suggesting that the growth factors released by the administered stem cells stimulate the remaining insulin-producing cells to reproduce. In addition, an immune suppressive effect is under discussion, which should reduce defective regulation and the associated damage caused to the pancreas.

Apart from diabetes, numerous studies have been conducted on the possible therapeutic benefit of stem cells from fat in a number of other organ diseases such as asthma, ulcerative colitis, erectile dysfunction and Crohn’s disease. The stem cells appear to stimulate the body to regenerate the respective organ and to suppress the overreaction of the immune system that underlies the disease.

I had joint problems for 8 years. My knees hurt when standing and walking and I could not do any sports. Then DDr. Heinrich transplanted stem cells from my own fat tissue to the damaged knee. Since then, a lot has changed: After almost 2 months, the pain disappeared. I can stand and walk without pain today. I am very satisfied and would do the surgery again.

Mrs. K., 55

Work in the construction business and on my farm has caused damage of my hip over the years. For about 20 years, I was so restricted that I even had to retire. I also could no longer pursue equitation in my free time. About two to three weeks after the hip treatment with my own fat stem cells I noticed an improvement. Now I can take longer walks without pain. I would do the procedure again anytime.

Georg N., 76

For 20 years, I suffered from knee pain and had to give up dancing and traveling. I read about the stem cell treatment in the Clinic DDr. Heinrich® in the newspaper. The doctor and his staff cared for me in a very competent and empathic way. About two weeks after the procedure, I noticed a significant improvement. On a ball I could dance without pain again and enjoy the evening on the dance floor! I am grateful for this increase in well-being.

Gertraude V., 79

Due to osteoarthritis in my knees I decided to get treated with stem cells in the clinic of DDr. Heinrich. Now, 3 months after having received the therapy, I can walk better and feel more stable with my knees. I am happy with this result and started doing Pilates and spinning again. I am very thankful to DDr. Heinrich and his team.

Mrs. de L., Belgium

20 years ago I first noticed pain in my knee. At some point I was only able to manage short walking distances and had to reduce sports activities. After unsuccessful therapies I read about DDr. Heinrich and the new treatment with fat stem cells. I decided to undergo stem cell treatment in his clinic. After the treatment there was a steady improvement. Today, I can again pursue all leisure activities such as cycling.

Dietmar R., Wien

Some years ago I was diagnosed with scleroderma with Raynaud’s syndrome. I spent a lot of time in the hospital without much success. Then I heard about the body’s own stem cells. Soon after the procedure I noticed the first positive changes. It is pleasant to wake up without pain. No one had expected that the inflammation of the skin would decline. I am very happy about the new quality of life.

Jana B., 35

Over the past 5 years, the pain in my forefeet has been getting worse. Standing upright and climbing stairs made me feel uncomfortable. Pain medications only led to a short improvement. The regenerative treatment with my own fat stem cells convinced me. After the treatment of my feet, I noticed that the pain was steadily declining. I do not need painkillers anymore and I can go for a walk again.

Ruža N., 59

For over 20 years, I suffered from pain when walking. Thanks to my stem cells, today I can climb stairs without pain and go hiking again! Just two, three weeks after the treatment performed by DDr. Heinrich I felt that my pain subsided and now it’s even better! I am excited and can recommend this treatment!

Mr. R., 76

The autologous stem cells needed for therapy are harvested from a small portion of fat, gently extracted using local anesthesia. The stem cells are introduced into the body immediately afterwards where their regenerative effect begins to work. The patient is fully mobile after treatment and can resume normal everyday activities.

Please note that no guarantees or promise of cure can be given in medicine generally; this also applies to advanced treatments such as stem cell therapy. Although we carry out your surgery with the greatest care and have achieved excellent results in part with stem cell treatment, adult stem cells are not a universal remedy.

Schedule appointment or Skype information now

  • Cho, K.S., Roh, H.J.: Immunomodulatory effects of adipose-derived stem cells in airway allergic diseases. Curr Stem Cell Res Ther June 2010; 5 (2): 111–5.
  • El-Badri, N., Ghoneim, M.A.: Mesenchymal Stem Cell Therapy in Diabetes Mellitus: Progress and Challenges. J Nucleic Acids 2013; 2013 (194858). Epub May 15, 2013.
  • Ezquer, F., Ezquer, M., Arango-Rodriguez, M., Conget, P.: Could donor multipotent mesenchymal stromal cells prevent or delay the onset of diabetic retinopathy?. Acta Ophthalmol June 15, 2013. Epub ahead of print.
  • Granel, B., Daumas, A., Jouve, E., et al.: Safety, tolerability and potential efficacy of injection of autologous adipose-derived stromal vascular fraction in the fingers of patients with systemic sclerosis: an open-label phase I trial. Ann Rheum Dis August 11, 2014. Epub ahead of print.
  • Kim, E.J., Kim, N., Cho, S.G.: The potential use of mesenchymal stem cells in hematopoietic stem cell transplantation. Exp Mol Med January 10, 2013; 45 (e2).
  • Kwon, E.B., Lee, J.Y., Piao, S., et al.: Comparison of human muscle-derived stem cells and human adipose-derived stem cells in neurogenic trans-differentiation. Korean J Urol December 2011; 52 (12): 852–7. Epub December 20, 2011.
  • Li, Q., Zhou, X., Shi, Y., et al.: In vivo tracking and comparison of the therapeutic effects of MSCs and HSCs for liver injury. PLoS One 2013; 8 (4): e62363. Epub April 30, 2013.
  • Lin, C.-S.: Advances in stem cell therapy for the lower urinary tract. World J Stem Cells February 26, 2010; 2 (1) 1–4.
  • Lin, G., Banie, L., Ning, H., et al.: Potential of adipose-derived stem cells for treatment of erectile dysfunction. J Sex Med March 2009; 6 (Suppl. 3): 320–7.
  • Okura, H., Komoda, H., Fumimoto, Y., et al.: Transdifferentiation of human adipose tissue-derived stromal cells into insulin-producing clusters. J Artif Organs 2009; 12 (2): 123–30. Epub June 18, 2009.
  • Panés, J., Van Assche, G., García-Olmo, D., et al.: Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn’s disease: a phase 3 randomised, double-blind controlled trial. Lancet September 24, 2016; 388 (10051): 1281–90, Epub July 29, 2016.
  • Reinders, M.E., Leuning, D.G., de Fijter, J.W., et al.: Mesenchymal Stromal Cell Therapy for Cardio Renal Disorders. Curr Pharm Des June 20, 2013. Epub ahead of print.
  • Timper, K., Seboek, D., Eberhardt, M., et al.: Human adipose tissue-derived mesenchymal stem cells differentiate into insulin, somatostatin, and glucagon expressing cells. Biochem Biophys Res Commun March 24, 2006; 341 (4): 1135–40. Epub January 26, 2006.
  • Tzouvelekis, A., Paspaliaris, V., Koliakos, G., et al.: A prospective, non-randomized, no placebo-controlled, phase Ib clinical trial to study the safety of the adipose derived stromal cells-stromal vascular fraction in idiopathic pulmonary fibrosis. J Transl Med 2013; 11 (171). Epub July 15, 2013.
  • Wang, H.-C., Brown, J., Alayon, H., Stuck, B.E.: Transplantation of quantum dot-labelled bone marrow-derived stem cells into the vitreous of mice with laser-induced retinal injury: survival, integration and differentiation. Vision Res March 31, 2010; 50 (7): 665–73. Epub September 25, 2009.
  • Zeppieri, M., Salvetat, M.L., Beltrami, A.P., et al.: Human adipose-derived stem cells for the treatment of chemically burned rat cornea: preliminary results. Curr Eye Res April 2013; 38 (4): 451–63. Epub February 1, 2013.
  • Zhao, W., Li, J.-J., Cao, D.-Y., et al.: Intravenous injection of mesenchymal stem cells is effective in treating liver fibrosis. World J Gastroenterol March 14, 2012; 18 (10): 1048–58. Epub March 14, 2012.

This page serves the purpose of information only and is not to be understood as medical advice. We would like to expressly point out that a cure cannot be guaranteed. Stem cell therapy is an advanced procedure, which has only recently been applied worldwide and for which the long-term studies and reliable documentation on successes, risks and side effects required for a recognized procedure are not yet available.

The legislation on stem cell therapies and conducting of new therapies varies from country to country worldwide. In our clinic in Austria we only carry out the treatments permitted under the applicable legal situation. For other treatments we have worldwide contacts in our cooperation network and can support the selection of specialized medical facilities abroad.

Your message to us